Chagas' cardiomyopathy: Prognosis in clinical and hemodynamic profile C;Cardiomiopatia chagásica: Prognóstico no perfil clínico-hemodinâmico C

Arquivos Brasileiros de Cardiologia

Volumn 95, Issue 4, 2010, Pages 518-523

  Cardoso, Juliano ^a   Novaes, Milena ^a   Ochiai, Marcelo ^a   Regina, Kelly ^a   Morgado, Paulo ^a   Munhoz, Robinson ^a   Brancalhão, Euler ^a   Lima, Marcelo ^a   Barretto, Antonio Carlos Pereira ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Chagas cardiomyopathy; Heart failure complications; Prognostic; Reperfusion

Indexed keywords

ADULT; AGED; ARTICLE; CHAGAS DISEASE; CHI SQUARE TEST; CLINICAL AND HEMODYNAMIC PROFILE C; CONTROLLED STUDY; FEMALE; FISHER EXACT TEST; FOLLOW UP; HEART HEMODYNAMICS; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PROGNOSIS; STUDENT T TEST; SYSTOLIC BLOOD PRESSURE;

EID: 78650723359     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2010005000112     Document Type: Article

References (20)

1. Sociedade Brasileira de Cardiologia/Federação Argentina de Cardiologia/Sociedade Chilena de Cardiologia. I Diretriz Latino-americana para avaliação e conduta na insuficiência cardíaca descompensada. Arq Bras Cardiol. 2005;85(supl. 3):49-94.
2. Sociedade Brasileira de Cardiologia. III Diretriz de insuficiência cardíaca crônica. Arq Bras Cardiol. 2009;93(1 supl. 1):1-71.
3. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The Consensus Trial Study Group. N Engl J Med. 1987;316(23):1429- 35.
4. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. The SOLVD investigators. N Engl J Med. 1991;325(5):293-302.
5. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med. 1999;341(10):709-17.
6. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomized trial. Lancet. 1999;353(9146):9-13.
7. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999;353(9169):2001-7.
8. Criteria Committee. New York Heart Association, Inc: Diseases of the heart and blood vessels: nomenclature and criteria for diagnosis. 6th ed. Boston: Little, Brown an Co; 1964.
9. Fonarow GC, Adams K F, Abraham W T, Yancy CW, Boscardin WJ. for the ADHERE Scientific advisory committee, Study Group and investigators. Risk stratification for in-hospital mortality in acutely decompensated heart failure. Classification and regression tree analysis. JAMA. 2005;293(5):572-80.
10. Stevenson LW. Tailored therapy to hemodynamic goals for advanced heart failure. Eur J Heart Fail. 1999;1(3):251-7.
11. Nohria A, Tsang SW, Fang JC. Clinical assessment identifies: hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol. 2003;41(10):1797-804.
12. Stevenson LW. Design of therapy for advanced heart failure. Eur J Heart Fail. 2005;7(3):323-31.
13. Nohria A, Lewis E, Stevenson L. Medical management os advanced heart failure. JAMA. 2002;287(5):628-39.
14. Freitas H F, Chizzola PR, Paes AT, Lima AC, Mansur AJ. Risk stratification in a Brazilian hospital-based cohort of 1220 outpatients with heart failure: role of chagas heart disease. Int J Cardiol. 2005;102(2):239-47.
15. Rassi S, Barretto ACP, Porto CC, Pereira CR, Calaça B W, Rassi DC. Sobrevida e fatores prognósticos na insuficiência cardíaca sistólica com início recente dos sintomas. Arq Bras Cardiol. 2005;4(4):309-13.
16. Silva C P, Del Carlo CH, Oliveira MT, Scipioni A, Strunz Cassaro C. Por que os portadores de cardiomiopatia chagásica têm pior evolução que os não chagásicos? Arq Bras Cardiol. 2008;91(6):389-94.
17. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-81.
18. Pereira-Barretto AC, Del Carlo CH, Cardoso JN, Morgado PC, Munhoz RT, Eid MO, et al. Re-hospitalizações e morte por insuficiência cardíaca. Índices ainda alarmantes. Arq Bras Cardiol. 2008;91(5):335-41.
19. Rassi Jr A, Rassi A, Little WC, Xavier SS, Rassi SG, Rassi AG, et al. Development and validation of risk score for predicting death in Chagas' heart disease. N Engl J Med. 2006;355(8):799-808.
20. Sociedade Brasileira de Cardiologia. II Diretriz brasileira de insuficiência cardíaca aguda. Arq Bras Cardiol. 2009;93(supl. 3):1-65.